Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development | News
Search Refinements

Drug Discovery & Development News

View news from other Pharmaceutical sectors:
31-45 of 4403 results
Scientists use kiss of death to neutralize disease-causing proteins
By PBR Staff Writer
Scientists at the University of Dundee in Scotland have discovered how to destroy undruggable cancer proteins that lead to several strains of the disease.
Drug Research > Drug Discovery & Development > News
Google’s venture arm leads $51.7m investment in Spero Therapeutics
Spero Therapeutics, a biopharmaceutical firm engaged in the development of novel therapies to treat bacterial infections, has completed a $51.7m Series C preferred financing led by new investor GV (formerly Google Ventures).
Drug Research > Drug Discovery & Development > News
Heat Biologics to acquire controlling stake in Pelican Therapeutics
Heat Biologics has agreed to buy an 80% controlling stake in Pelican Therapeutics, a privately held immuno-oncology company engaged in the development of agonists to TNFRSF25, a differentiated T cell costimulatory receptor.
Drug Research > Drug Discovery & Development > News
Bioversys, Aptuit partner to find novel antibiotic targets
Bioversys and Aptuit have commenced their joint collaboration to identify and validate novel targets and molecules for Gram-negative bacteria.
Drug Research > Drug Discovery & Development > News
Vertex to buy cystic fibrosis drug from Concert Pharmaceuticals
Vertex Pharmaceuticals has agreed to acquire CTP-656 from Concert Pharmaceuticals to treat cystic fibrosis.
Drug Research > Drug Discovery & Development > News
FDA accepts Advaxis' IND for personalized neoepitope immunotherapy ADXS-NEO
The US Food and Drug Administration (FDA) has accepted Advaxis’ Investigational New Drug (IND) application for ADXS-NEO, a personalized neoantigen-targeted approach to cancer immunotherapy that is being developed in partnership with Amgen.
Drug Research > Drug Discovery & Development > News
AstraZeneca’s MedImmune, Sanofi partner to develop infant respiratory drug
By PBR Staff Writer
AstraZeneca’s biologics research and development arm MedImmune and Sanofi Pasteur have agreed to a potential €615m collaboration to develop a monoclonal antibody (mAb) treatment for respiratory syncytial virus (RSV).
Drug Research > Drug Discovery & Development > News
Abzena, UCL secure £3.5m grant from MRC for autoimmune therapy research
A research group from University College London's (UCL) Centre for Rheumatology has been awarded a £3.5m grant from the Medical Research Council (MRC) to advance the development of a novel treatment for anti-phospholipid syndrome (APS) based on Abzena's conjugation technology.
Drug Research > Drug Discovery & Development > News
Astellas, Affinivax to develop MAPS vaccine targeting pneumococcal disease
Affinivax and Astellas Pharma have signed an exclusive worldwide license agreement to develop and market a vaccine targeting Streptococcus pneumoniae (pneumococcus).
Drug Research > Drug Discovery & Development > News
WHO reaffirms critical need for R&D for drug-resistant tuberculosis
The World Health Organization (WHO) has stressed the urgent requirement for research and development (R&D) of new antibiotics to handle the threat posed by drug-resistant tuberculosis (TB).
Drug Research > Drug Discovery & Development > News
Pharma Two B raises $30m for trial of Parkinson's treatment
Pharma Two B, a privately held biopharmaceutical firm engaged in the development of treatments for Parkinson’s disease, has closed $30m financing round.
Drug Research > Drug Discovery & Development > News
Advaxis licenses antigen delivery technology to Sellas for cancer immunotherapy development
Advaxis has licensed its Lm-based antigen delivery technology to Sellas, under a cancer immunotherapy collaboration that could generate up to $358m for Advaxis.
Drug Research > Drug Discovery & Development > News
Incyte partners with University of Pennsylvania on cancer immunotherapy research
Incyte has entered into multi-year research collaboration with the Abramson Cancer Center at the University of Pennsylvania.
Drug Research > Drug Discovery & Development > News
PMV Pharma raises $74m for cancer drugs targeting p53
PMV Pharmaceuticals, which is engaged in the discovery and development of p53-targeted small molecule drugs for the treatment of cancer, has completed a $74m Series B financing round.
Drug Research > Drug Discovery & Development > News
Modus Therapeutics raises £2.9m to support further development of sevuparin for SCD
Modus Therapeutics has raised SEK32m (£2.9m) from existing investors KDev Investments, Östersjöstiftelsen and Praktikerinvest to support a phase two study of a sickle cell disease (SCD) drug.
Drug Research > Drug Discovery & Development > News
31-45 of 4403 results